SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)	Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, brain disorder, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder	Recruiting	Not applicable	2023-12-15		NCT05689619

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
A.O.U. Città della Salute e della Scienza	19

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Azienda Ospedaliera Città della Salute e della Scienza di Torino	Turin	Italy	1
Institute of Neurosurgery, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Catholic University	Rome	Italy	1
Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute	Rome	Italy	1
Neurosurgery Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina	Messina	Italy	1
Precision Medicine in Breast Cancer Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Rome	Italy	1
Unità Operativa di Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino di Genova	Genova	Italy	1